Literature DB >> 20810735

Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytes.

Amit Raychoudhuri1, Shubham Shrivastava, Robert Steele, Srikanta Dash, Tatsuo Kanda, Ranjit Ray, Ratna B Ray.   

Abstract

Hepatitis C virus (HCV) establishes chronic infection in a significant number of infected humans, although the mechanisms for chronicity remain largely unknown. We have previously shown that HCV infection in immortalized human hepatocytes (IHH) induces beta interferon (IFN-β) expression (T. Kanda, R. Steele, R. Ray, and R. B. Ray, J. Virol. 81:12375-12381, 2007). However, the regulation of the downstream signaling pathway for IFN-α production by HCV is not clearly understood. In this study, the regulation of the IFN signaling pathway following HCV genotype 1a (clone H77) or genotype 2a (clone JFH1) infection of IHH was examined. HCV infection upregulated expression of total STAT1 but failed to induce phosphorylation and efficient nuclear translocation. Subsequent study revealed that HCV infection induces IFN-stimulated response element activation, as evidenced by upregulation of 2',5'-oligoadenylate synthetase 1. However, nuclear translocation of IRF-7 was impaired following HCV infection. In HCV-infected IHH, IFN-α expression initially increased (up to 24 h) and then decreased at later time points, and IFN-α-inducible protein 27 was not induced. Interestingly, HCV infection blocked IRF-7 nuclear translocation upon poly(I-C) or IFN-α treatment of IHH. Together, our data suggest that HCV infection enhances STAT1 expression but impairs nuclear translocation of IRF-7 and its downstream molecules. These impairments in the IFN-α signaling pathway may, in part, be responsible for establishment of chronic HCV infection.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20810735      PMCID: PMC2953153          DOI: 10.1128/JVI.00900-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

Review 1.  Alternative and accessory pathways in the regulation of IFN-beta-mediated gene expression.

Authors:  M R Sandhya Rani; Richard M Ransohoff
Journal:  J Interferon Cytokine Res       Date:  2005-12       Impact factor: 2.607

Review 2.  Interferon-induced antiviral actions and their regulation.

Authors:  G C Sen; R M Ransohoff
Journal:  Adv Virus Res       Date:  1993       Impact factor: 9.937

Review 3.  Mx proteins: mediators of innate resistance to RNA viruses.

Authors:  O Haller; M Frese; G Kochs
Journal:  Rev Sci Tech       Date:  1998-04       Impact factor: 1.181

4.  Distinct poly(I-C) and virus-activated signaling pathways leading to interferon-beta production in hepatocytes.

Authors:  Kui Li; Zihong Chen; Nobuyuki Kato; Michael Gale; Stanley M Lemon
Journal:  J Biol Chem       Date:  2005-02-28       Impact factor: 5.157

5.  Hepatitis C virus expression suppresses interferon signaling by degrading STAT1.

Authors:  Wenyu Lin; Won Hyeok Choe; Yoichi Hiasa; Yoshitaka Kamegaya; Jason T Blackard; Emmett V Schmidt; Raymond T Chung
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

6.  Intrahepatic gene expression during chronic hepatitis C virus infection in chimpanzees.

Authors:  Catherine B Bigger; Bernadette Guerra; Kathleen M Brasky; Gene Hubbard; Michael R Beard; Bruce A Luxon; Stanley M Lemon; Robert E Lanford
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

7.  Regulating intracellular antiviral defense and permissiveness to hepatitis C virus RNA replication through a cellular RNA helicase, RIG-I.

Authors:  Rhea Sumpter; Yueh-Ming Loo; Eileen Foy; Kui Li; Mitsutoshi Yoneyama; Takashi Fujita; Stanley M Lemon; Michael Gale
Journal:  J Virol       Date:  2005-03       Impact factor: 5.103

8.  Generation of infectious hepatitis C virus in immortalized human hepatocytes.

Authors:  Tatsuo Kanda; Arnab Basu; Robert Steele; Takaji Wakita; Jan S Ryerse; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

9.  Tumor suppressor function of the interferon-induced double-stranded RNA-activated protein kinase.

Authors:  E F Meurs; J Galabru; G N Barber; M G Katze; A G Hovanessian
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-01       Impact factor: 11.205

10.  Hepatitis C virus protease NS3/4A cleaves mitochondrial antiviral signaling protein off the mitochondria to evade innate immunity.

Authors:  Xiao-Dong Li; Lijun Sun; Rashu B Seth; Gabriel Pineda; Zhijian J Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-21       Impact factor: 11.205

View more
  29 in total

1.  Hepatitis C virus-induced cancer stem cell-like signatures in cell culture and murine tumor xenografts.

Authors:  Naushad Ali; Heba Allam; Randal May; Sripathi M Sureban; Michael S Bronze; Ted Bader; Shahid Umar; Srikant Anant; Courtney W Houchen
Journal:  J Virol       Date:  2011-09-21       Impact factor: 5.103

2.  Knockdown of autophagy enhances the innate immune response in hepatitis C virus-infected hepatocytes.

Authors:  Shubham Shrivastava; Amit Raychoudhuri; Robert Steele; Ranjit Ray; Ratna B Ray
Journal:  Hepatology       Date:  2011-01-10       Impact factor: 17.425

3.  Hepatitis C virus-mediated enhancement of microRNA miR-373 impairs the JAK/STAT signaling pathway.

Authors:  Anupam Mukherjee; Adrian M Di Bisceglie; Ratna B Ray
Journal:  J Virol       Date:  2015-01-14       Impact factor: 5.103

4.  Transcriptional repression of C4 complement by hepatitis C virus proteins.

Authors:  Arup Banerjee; Budhaditya Mazumdar; Keith Meyer; Adrian M Di Bisceglie; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

5.  Classical swine fever virus N(pro) limits type I interferon induction in plasmacytoid dendritic cells by interacting with interferon regulatory factor 7.

Authors:  Ana R Fiebach; Laurence Guzylack-Piriou; Sylvie Python; Artur Summerfield; Nicolas Ruggli
Journal:  J Virol       Date:  2011-06-15       Impact factor: 5.103

6.  Direct, interferon-independent activation of the CXCL10 promoter by NF-κB and interferon regulatory factor 3 during hepatitis C virus infection.

Authors:  Jessica Brownell; Jacob Bruckner; Jessica Wagoner; Emmanuel Thomas; Yueh-Ming Loo; Michael Gale; T Jake Liang; Stephen J Polyak
Journal:  J Virol       Date:  2013-11-20       Impact factor: 5.103

Review 7.  Natural interferon-beta treatment for patients with chronic hepatitis C in Japan.

Authors:  Reina Sasaki; Tatsuo Kanda; Shingo Nakamoto; Yuki Haga; Masato Nakamura; Shin Yasui; Xia Jiang; Shuang Wu; Makoto Arai; Osamu Yokosuka
Journal:  World J Hepatol       Date:  2015-05-18

8.  Hepatitis C virus impairs TLR3 signaling and inhibits IFN-λ 1 expression in human hepatoma cell line.

Authors:  Yizhong Wang; Jieliang Li; Xu Wang; Li Ye; Yu Zhou; Rebecca M Thomas; Wenzhe Ho
Journal:  Innate Immun       Date:  2013-03-25       Impact factor: 2.680

9.  The modulation of hepatitis C virus 1a replication by PKR is dependent on NF-kB mediated interferon beta response in Huh7.5.1 cells.

Authors:  Lumin Zhang; Harvey J Alter; Haiping Wang; Shuaizheng Jia; Ena Wang; Francesco M Marincola; James W-K Shih; Richard Y Wang
Journal:  Virology       Date:  2013-02-09       Impact factor: 3.616

10.  Interferon regulatory factor 5 (IRF5) suppresses hepatitis C virus (HCV) replication and HCV-associated hepatocellular carcinoma.

Authors:  Ozge Cevik; Dan Li; Erdene Baljinnyam; Dinesh Manvar; Erica M Pimenta; Gulam Waris; Betsy J Barnes; Neerja Kaushik-Basu
Journal:  J Biol Chem       Date:  2017-10-27       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.